Influence
July 16, 2020

Regenstrief research scientist shares ICU experience during Side Effects COVID-19 panel

Regenstrief research scientist shares ICU experience during Side Effects COVID-19 panel

Regenstrief research scientist Sikandar Khan, D.O., shared his perspective from working in the intensive care unit (ICU) in the midst of the COVID-19 outbreak during a panel hosted by Side Effects Public Media and Indiana Public Broadcasting.

Dr. Khan has been treating patients in the ICU at Indiana University Health Methodist Hospital throughout the COVID-19 pandemic. He spoke about how data has helped guide decisions in the ICU, allowing clinicians to anticipate surges in cases and plan for equipment and personnel needs.

He also talked about the potentially long recovery COVID-19 survivors face. Patients who need intensive care, especially those who are put on ventilators, are at risk for post intensive care syndrome. This can affect the patient’s body as well as the mind. Dr. Khan said he and his colleagues are closely watching to see what recovery will look like for COVID-19 patients.

Dr. Khan also lauded his colleagues for adapting to the stressful situation and their tireless work to take care of patients. He urged everyone to continue taking precautions, including social distancing and wearing masks.

Watch the entire panel here

Related News

image of pregnant woman with vaccine acting as protection from COVID virus

National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two

Thomas Imperiale

Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds

It’s been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., discusses the questions that will be investigated in

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Widely used scales measure pain, depression, anxiety, suicide risk, cancer fatigue and now symptoms associated with a common dental